PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ipratropium with salbutamol - Respiratory disease indications
PAD Profile : Ipratropium with salbutamol - Respiratory disease indications Important
Keywords :
Nebules, COPD, bronchospasm
Brand Names Include :
Combivent
Important Information :
Severe respiratory disease.
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Nebules
Important Information :
Primary Care may prescribe on recommendation from the Respiratory Care Team who will ensure that patients have had suitable training and trial of equipment to ensure safe use.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Respiratory Care Team will ensure that the patient has undergone a suitable trial and training re: use of equipment, response and safety. After this trial GPs may prescribe following a request from the respiratory care team. The advice will include frequency and duration of treatment, and whether additional support is required for the patients, e.g. wrap-around, frequent or long-term steroids.
Associated BNF Codes
03. Respiratory System
03.01.04. Compound bronchodilator preparations